KRON(Delisted)
Kronos BioยทNASDAQ
--
--(--)
KRON Profile
Kronos Bio, Inc.
A company that develops therapeutics for cancer by targeting dysregulated transcription
301 Binney Street, 2nd Floor East, Cambridge, MA 02142
--
Kronos Bio, Inc. was incorporated under the laws of the State of Delaware on June 2, 2017. The company is a clinical-stage biopharmaceutical company dedicated to the discovery and development of new cancer therapies designed to change patient outcomes through precise drug strategies targeting dysregulated transcription.
